Why exercise has become a key part of cancer treatment
Analysis & Insights
Exercise can ease fatigue and may improve survival. Stanford experts explain the evidence and how patients can safely add movement to their care.
How mental health and cancer survivorship intersect
Q&A
Researchers discuss a new study linking mental health disorders to poorer cancer survival – and why support should extend beyond initial treatment.
Powerful X-rays reveal enzymes in action
Research
Using SLAC’s Linac Coherent Light Source, researchers created “molecular movies” of an enzyme linked to cancer and another essential to penicillin production.
New urine test could improve bladder cancer diagnosis
Research
An RNA-based urine test shows promise for detecting bladder cancer, predicting treatment response, and identifying cancer remaining after treatment.
Community-first approach guides cancer center vision
Research
Input from local residents is helping to shape Stanford Medicine’s proposed clinical cancer care and research center in Redwood City.
Scientists rethink how we sequence human genomes
Q&A
Professor Euan Ashley breaks down why the field’s 20-year-old reference genome falls short – and how a more complete “pangenome” could sharpen precision medicine.
‘Molecular glue’ turns cancer driver into built-in kill switch
Research
A Stanford Medicine-designed molecule turns BCL6, a protein that helps drive lymphoma, into a trigger for cancer-cell death.
A Stanford gynecologist’s guide to menopause after breast cancer
Analysis & Insights
Clinical assistant professor Kathryne Sanserino explains why menopause can be especially intense after breast cancer treatment and how personalized, nonhormonal treatment options can help.
What bemotrizinol could mean for U.S. sun protection
Analysis & Insights
The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts share why it’s considered a massive leap forward for skin health in the U.S.
Why is colorectal cancer rising in adults under 50?
Q&A
Colorectal cancer is now the No. 1 cause of cancer deaths among people under age 50. Here’s what Stanford Medicine experts want you to know.